Mark E. Strome, 10% Owner at Zivo Bioscience, Inc. (ZIVO), bought 75,000 shares at $20.19 ($1.5M) on 2024-12-26, disclosed to the SEC on 2024-12-31.
Open-market purchase of $1.5M ZIVO by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Negative factors outweigh the positive ones.
| Filing → |
| BEAT | SELL | 2025-12-22 | $895K | — | Filing → |
| AREN | SELL | 2025-01-23 | $372K | — | Filing → |
| MVEN | BUY | 2018-10-04 | $1.4M | — | Filing → |